Clinical Trials Logo

Clinical Trial Summary

Atypical antipsychotics have been found not only to be beneficial in the treatment of psychotic disorders, but even for depressive symptoms in patients with schizophrenia. Remarkably, preliminary data suggest that the atypical antipsychotic quetiapine has antidepressive properties. Until now, there is limited knowledge concerning the efficacy of quetiapine in major depressive illness and especially in psychotic depression. In our own clinical practice, several patients with psychotic depression were successfully treated with quetiapine as add-on therapy or as monotherapy. On the background of that, the convincing effects of quetiapine in bipolar depression, single-case reports and pilot studies concerning its effectiveness in depressive mood states in psychotic disorders as well as our clinical experiences, it is to assume that a treatment with quetiapine over a 6 weeks period show similar effects in major depressive episode with psychotic features, i.e. psychotic depression. In this pilot study we plan to investigate 20 patients with psychotic features of depression under treatment with quetiapine.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00751504
Study type Interventional
Source Ruhr University of Bochum
Contact
Status Completed
Phase Phase 3
Start date September 2008
Completion date July 2012

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06005766 - The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care N/A
Not yet recruiting NCT05034523 - Voxel Based Morphometry In Patients With Psychotic Versus Non Psychotic Depression
Completed NCT02782442 - Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) N/A
Completed NCT01427608 - Sustaining Remission of Psychotic Depression Phase 4
Terminated NCT00637494 - A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features Phase 3
Completed NCT00556140 - The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression Phase 3
Completed NCT00400166 - Recovery Guide Intervention for Recurrent Psychiatric Hospitalization N/A